您当前所在的位置:首页 > 产品中心 > 产品详细信息
51264-14-3 分子结构
点击图片或这里关闭

N-{4-[(acridin-9-yl)amino]-3-methoxyphenyl}methanesulfonamide

ChemBase编号:161
分子式:C21H19N3O3S
平均质量:393.45886
单一同位素质量:393.11471248
SMILES和InChIs

SMILES:
S(=O)(=O)(Nc1cc(OC)c(Nc2c3c(nc4c2cccc4)cccc3)cc1)C
Canonical SMILES:
COc1cc(ccc1Nc1c2ccccc2nc2c1cccc2)NS(=O)(=O)C
InChI:
InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)
InChIKey:
XCPGHVQEEXUHNC-UHFFFAOYSA-N

引用这个纪录

CBID:161 http://www.chembase.cn/molecule-161.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
N-{4-[(acridin-9-yl)amino]-3-methoxyphenyl}methanesulfonamide
IUPAC传统名
amsacrine
商标名
Amsidine
Amsidyl
Amsine
AMSA P-D
别名
Acridinyl Anisidide
M-AMSA
MAMSA
Amsacrine
CAS号
51264-14-3
PubChem SID
160963624
46507539
PubChem CID
2179

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB00276 external link
PubChem 2179 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 10.824813  质子受体
质子供体 LogD (pH = 5.5) 1.4867606 
LogD (pH = 7.4) 2.164806  Log P 3.1616213 
摩尔折射率 107.6901 cm3 极化性 44.860916 Å3
极化表面积 80.32 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 4.66  LOG S -5.09 
溶解度 3.17e-03 g/l 

分子性质

分子性质

理化性质 生物活性(PubChem)
溶解度
<1 mg/mL expand 查看数据来源
疏水性(logP)
3.8 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB00276 external link
Item Information
Drug Groups approved
Description Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem]
Indication For treatment of acute myeloid leukaemia.
Pharmacology Amsacrine is an aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
Toxicity Symptoms of overdose include nausea and vomiting, diarrhea, some cardiotoxicity (rarely).
Affected Organisms
Humans and other mammals
Biotransformation Extensive, primarily hepatic, converted to glutathione conjugate.
Absorption Poorly absorbed
Half Life 8-9 hours
Protein Binding 96-98%
References
[Link]
External Links
Wikipedia

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle